AbbVie and Genmab’s epcoritamab has shown promise as part of a combination treatment for relapsed or refractory follicular ...

Empathy is a core capability, regardless of function – our ability to connect with others and understand how information is ...

This year’s ASCO® meeting spotlighted a bold shift in oncology: the possibility of curing metastatic disease. A new trial ...

ASCO® 2025 wasn’t only about oncology breakthroughs - it was also a showcase for how technology is redefining congress ...

In a crowded oncology market, strategy-led storytelling, analytics-driven design, and sustainability-centered innovation are ...